Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 1 - Issue 1 - Sept/Oct 2004

Feature

Original Research
Excimer Laser-Assisted Angioplasty in Severe Infrapopliteal Disease and CLI: The CIS LACI Equivalent Experience
09/05/2008
The TransAtlantic Inter-Societal Consensus committee and document on the management of peripheral arterial occlusive disease have recently attempted to unify and clarify CLI with the following recommendations.
The TransAtlantic Inter-Societal Consensus committee and document on the management of peripheral arterial occlusive disease have recently attempted to unify and clarify CLI with the following recommendations.
The TransAtlantic Inter-Societal...
09/05/2008
Vascular Disease Management
Case Report
Percutaneous Mechanical Thrombectomy Combined With Thrombolysis for the Treatment of Deep Venous Thrombosis
09/05/2008

Lin, MD; Bush, MD

Lin, MD; Bush, MD
Multiple sequelae may occur after deep venous thrombosis (DVT), including acute limb symptoms such as swelling and pain, valvular damage and reflux leading to chronic symptoms, and, the most serious, pulmonary embolism and death.
Multiple sequelae may occur after deep venous thrombosis (DVT), including acute limb symptoms such as swelling and pain, valvular damage and reflux leading to chronic symptoms, and, the most serious, pulmonary embolism and death.
Multiple sequelae may occur...
09/05/2008
Vascular Disease Management
Case Report
Intracranial Middle Cerebral Artery Percutaneous Intervention Using a Drug-Eluting Stent
09/05/2008
Intracranial angioplasty and stenting are increasingly being used to treat patients with recurrent cerebral ischemia due to intracranial atherosclerosis, which is a cause of 8-10% of all ischemic strokes.
Intracranial angioplasty and stenting are increasingly being used to treat patients with recurrent cerebral ischemia due to intracranial atherosclerosis, which is a cause of 8-10% of all ischemic strokes.
Intracranial angioplasty and...
09/05/2008
Vascular Disease Management
Original Research
Bivalirudin in Peripheral Vascular Interventions: A Single Center Experience
09/05/2008
Unfractionated heparin is the current antithrombotic agent utilized during peripheral angioplasty procedures.
Unfractionated heparin is the current antithrombotic agent utilized during peripheral angioplasty procedures.
Unfractionated heparin is the...
09/05/2008
Vascular Disease Management
Update
Update: Bivalirudin in Peripheral Vascular Intervention
09/05/2008
Despite the sharp rise in peripheral vascular interventions (PVI), complication rates have continued to be significant and, in fact, limb loss has trended upwards.
Despite the sharp rise in peripheral vascular interventions (PVI), complication rates have continued to be significant and, in fact, limb loss has trended upwards.
Despite the sharp rise in...
09/05/2008
Vascular Disease Management
Case Report
Multidetector Computerized Tomography for the Evaluation of Cerebrovascular Disease: A Case Study
09/05/2008
A 59-year-old hypertensive, diabetic, white male ex-smoker with a history of CABG in 1994. In 1997, he underwent insertion of a pacemaker for bradycardia. In 1999, he was diagnosed with squamous cell laryngeal cancer by biopsy.
A 59-year-old hypertensive, diabetic, white male ex-smoker with a history of CABG in 1994. In 1997, he underwent insertion of a pacemaker for bradycardia. In 1999, he was diagnosed with squamous cell laryngeal cancer by biopsy.
A 59-year-old hypertensive,...
09/05/2008
Vascular Disease Management

Insights

Interview
Percutaneous Intraspinal Navigation (PIN)
09/05/2008
Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal cord to navigate in and around the brain and spinal cord.
Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal cord to navigate in and around the brain and spinal cord.
Just as we’ve been using the...
09/05/2008
Vascular Disease Management
Interview
Percutaneous Revascularization for SFA/Popliteal Arterial Disease: When and Why
09/05/2008
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI...
09/05/2008
Vascular Disease Management

Column

Editor's Corner
Welcome to Vascular Disease Management
09/05/2008
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and...
09/05/2008
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

September 2004 Volume 1 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement